Cystatin C Detection Reagent (Immunofluorescence Chromatography) (CysC) Performance Index

CysC overview

The cysteine proteinase inhibitor (CPI) is known as cystatin C. Cycle in inhibition of C is cleared after the glomerular filtration, only is a kind of endogenous markers to reflect the actual changes in glomerular filtration rate, and in the proximal convoluted tubule reuptake, but were completely after heavy absorption metabolism decomposition, do not return the blood, therefore, its blood concentration is determined by glomerular filtration rate, and not dependent on any external factors, such as gender, age, diet, It is an ideal endogenous marker to reflect the change of glomerular filtration rate.

CysC performance index

Clinical significance of CysC

• The ideal endogenous marker for GFR
• Early diagnosis and monitoring of renal diseases
• Renal function assessment in high-risk groups for AKI

Comparison of sensitivity of cystatin C and serum creatinine to assess GFR

Application Department

Internal medicine, pediatrics, orthopedics, cardiology, gynecology, obstetrics and Gynecology, emergency, ICU, Nephrology,

Clinical comparison of CysC

Company profile

Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.

Zhongxiu Science And Technology Co.,Ltd., founded in 2016, is located in Dingluan Industrial Zone, Changyuan City, Henan Province. The company covers an area of about 100 acres and the initial investment is about 200 million yuan. The company has a scientific and complete management system, a purification workshop of national standards, and a fully functional inspection center. On this basis, the company will continue to invest in research and development, accumulate technical strength, update manufacturing equipment, improve production technology, improve inspection technology, improve product quality, and provide customers with safe and effective in vitro diagnostic products.

Zhongxiu Science And Technology Co., Ltd. is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, immune series, microbial series and other reagents and supporting instruments.

The company has always adhered to the core concept of “fast and accurate, living up to life”, committed to providing society with excellent products and services, and contributing to the cause of human health.